Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterActive in the last 2 years

Yoshiyasu Kato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2203-256X; OpenAlex author ID A5060906966. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 4 papers · 2026: 6 papers

Papers 13

  1. Outcomes of conversion surgery for patients with locally advanced pancreatic cancer under strict indication criteria. Co-author DOI 10.1007/s00595-025-03223-7↗
  2. Intraoperative decision-making for pancreatic ductal adenocarcinoma with occult para-aortic lymph node metastasis: Proposal of a pathology-based weighted risk … Co-author DOI 10.1016/j.suronc.2026.102559↗
  3. Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. Co-author DOI 10.1245/s10434-025-18556-3↗
  4. Prognostic Significance of Radiological Adjacent Organ Invasion in Resectable Left-Sided Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-19244-6↗
  5. ASO Author Reflections: Rethinking Resectability in Left-Sided Pancreatic Cancer-The Clinical Meaning of Radiological Adjacent Organ Invasion. Co-author DOI 10.1245/s10434-026-19394-7↗
  6. ASO Visual Abstract: Prognostic Significance of Radiological Adjacent Organ Invasion in Resectable Left-Sided Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-19416-4↗
  7. Association Between the Degree of Arterial Contact Angle and Survival in Patients With Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1002/ags3.70052↗
  8. Clinical significance of resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma with occult para-aortic lymph node metastasis. Co-author DOI 10.1016/j.surg.2024.10.016↗
  9. Impact of Perioperative Hemoglobin A1c Levels on Survival Outcomes of Patients With Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.1097/as9.0000000000000597↗
  10. Efficacy of Neoadjuvant Therapy for Resectable Pancreatic Cancer Might be Limited to Biologically Borderline Resectable Cases. Co-author DOI 10.1097/mpa.0000000000002485↗
  11. New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS). Co-author DOI 10.1002/jhbp.1049↗
  12. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer. Co-author DOI 10.1016/j.hpb.2019.01.012↗
  13. Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001105↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Teiichi Sugiura · 10 shared papers, 2025–2026 · strength 2.74
  2. Ryo Ashida · 10 shared papers, 2025–2026 · strength 2.74
  3. Katsuhiko Uesaka · 10 shared papers, 2025–2026 · strength 2.74
  4. Katsuhisa Ohgi · 10 shared papers, 2025–2026 · strength 2.74
  5. Mihoko Yamada · 4 shared papers, 2025–2026 · strength 1.06
  6. Takumi Kitahama · 3 shared papers, 2026 · strength 0.90
  7. Kentaro Yamazaki · 2 shared papers, 2025 · strength 0.52
  8. Jun Shibamoto · 2 shared papers, 2025–2026 · strength 0.52
  9. Tomoko Norose · 1 shared paper, 2026 · strength 0.26
  10. Keiichi Ohshima · 1 shared paper, 2026 · strength 0.24
  11. Kenichi Urakami · 1 shared paper, 2026 · strength 0.24
  12. Ken D Yamaguchi · 1 shared paper, 2026 · strength 0.24
  13. Yuya Miura · 1 shared paper, 2026 · strength 0.24
  14. Yukiyasu Okamura · 1 shared paper, 2026 · strength 0.24
  15. Hidemasa Kubo · 1 shared paper, 2025 · strength 0.24
  16. Mitsuro Kanda · 2 shared papers, 2018–2019 · strength 0.16
  17. Masamichi Hayashi · 2 shared papers, 2018–2019 · strength 0.16
  18. Suguru Yamada · 2 shared papers, 2018–2019 · strength 0.16
  19. Yasuhiro Kodera · 2 shared papers, 2018–2019 · strength 0.16
  20. Y. H. Andrew Wu · 1 shared paper, 2022 · strength 0.12
  21. Yosuke Inoue · 1 shared paper, 2022 · strength 0.12
  22. Sohei Satoi · 1 shared paper, 2022 · strength 0.12
  23. Shuji Isaji · 1 shared paper, 2022 · strength 0.12
  24. Thilo Hackert · 1 shared paper, 2022 · strength 0.12
  25. Kyohei Ariake · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.